“Sarecycline exhibits decreased activity Against Representative Bacterial and Fungal Microflora Commonly Present in the Human Gastrointestinal Tract” (2021) SKIN The Journal of Cutaneous Medicine, 5(6), p. s83. doi:10.25251/skin.5.supp.83.